What is the latest data on the NSA IDR Process and OON reimbursement?

For more information on the new FDA breast density notification requirements, view this resource. For more information on the Find It Early Act and to view what legislation your state has in place, click here. Additional Resources: End the ConfusionUSPSTF Screening Recommendations and ACR ResponseACR Breast Cancer Screening GuidelinesFind It Early Act (US HR 3086)

Click here to view the website for Proposition 35. 

If you have not yet listened to Ed Gaines' episode on how bad payor policies and tactics are impacting emergency physicians in 2024, you can listen here. 

In this episode of Zotec Answers, Ed Gaines provides an update on the latest developments in the litigation regarding the No Surprises Act (NSA) and discusses the meaning and significance of the appellate court's decision in this case.

In this episode of Zotec Answers, Ed Gaines discusses the impact of unfair practices by major health insurers on emergency medicine physicians. He explores how these practices not only affect emergency medicine but also have broader implications across various healthcare specialties, especially in the context of the evolving nature of healthcare and revenue cycle management.

Access the white paper mentioned in the podcast episode here.

In this episode of Zotec Answers, Ed Gaines provides an overview of the Supreme Court case that overturned the Chevron deference doctrine and discusses the implications this decision could have on healthcare.

In the latest episode of Zotec Answers, Ed Gaines discusses the latest data on the No Surprises Act (NSA) Independent Dispute Resolution (IDR) Process and Out-of-Network (OON) reimbursement.

In this episode, Mark Isenberg discusses the critical healthcare issues voters must consider before casting their ballots, including Medicare physician reimbursement, the No Surprises Act, physician shortages, and the importance of electing knowledge healthcare professionals into office.

In this episode, Ed Gaines discusses the new FTC final rule banning noncompete agreements, its key provisions, exceptions, and potential impacts on healthcare, including its implications for physicians and healthcare organizations.